Clinical Trial Update: Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on first-line therapy using bevacizumab and sorafenib for locally advanced or metastatic liver cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-02